AlphaYouSK
Insider selling
Suma Krishnan sold $7.7M of Krystal Biotech, Inc. (KRYS) stock
Suma Krishnan, President, R&D, 10% of Krystal Biotech, Inc. (KRYS), sold 25,000 shares of KRYS stock worth $7.7M, per an SEC Form 4 filed Jun 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 4, 2026, 1 day before it was made public.
KRYS has moved +8.5% since the trade date, from $307.79 to $333.85 (Sep 21, 2026 close).
- Traded
- Jun 4, 2026
- Disclosed
- Jun 5, 2026
- Filing delay
- 1 day
- Price since
- +8.5%
- Role
- President, R&D, 10%
- Source
- SEC Form 4
More KRYS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.